Timeline

Caroline Demangel
Head of Structure
22 May 2024
project

Primary keratinocytes biobank to generate epidermal organoids EpiOrganoids

Read more
17 Jan 2024
project

TRANSLOCK-ER – Sec61 inhibitors for Oncology

Read more
17 Jan 2024
project

BAXERNA – Next generation Bacterial mRNA vaccines

Read more
17 Jan 2024
project

ERC-Syg-2023 DRIMMS

Read more
23 Nov 2023
publication

Host-pathogen interactions from a metabolic perspective: methods of investigation.

Read more
30 May 2023
publication

From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.

Read more
18 May 2023
publication

Nutrient-dependent regulation of β-cell proinsulin content.

Read more
24 Mar 2023
publication

Defensive-lipid droplets: Cellular organelles designed for antimicrobial immunity.

Read more
24 Jan 2023
publication

Click-chemistry-based protocol to quantitatively assess fatty acid uptake by Mycobacterium tuberculosis in axenic culture and inside mouse macrophages.

Read more
01 Jan 2023
publication

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Read more
25 Oct 2022
news

ERC Synergy grant 2022: congratulations to Caroline Demangel

Read more
07 Mar 2022
publication

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

Read more
11 Jan 2022
news

New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Read more
01 Jan 2022
publication

Mycolactone Purification from M. ulcerans Cultures and HPLC-Based Approaches for Mycolactone Quantification in Biological Samples.

Read more
01 Jan 2022
publication

Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.

Read more
24 Dec 2021
publication

De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.

Read more
01 Sep 2021
publication

Insights into the ancestry evolution of the Mycobacterium tuberculosis complex from analysis of Mycobacterium riyadhense.

Read more
04 May 2021
program_project

Emerging Infectious Diseases

Read more
19 Feb 2021
publication

Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.

Read more
08 Feb 2021
publication

Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis.

Read more
01 Jan 2021
publication

Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone.

Read more
01 Jan 2021
publication

Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities.

Read more
17 Dec 2020
project

Deci VERNEUIL – Etiology of Hidradenitis Suppurativa

Read more
11 Dec 2020
publication

Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system.

Read more
01 Dec 2020
publication

Spatiotemporal analysis of mycolactone distribution in vivo reveals partial diffusion in the central nervous system.

Read more
23 Oct 2020
publication

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Read more
16 Oct 2020
publication

Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJ.

Read more
02 Oct 2020
publication

Mycolactone induces cell death by SETD1B-dependent degradation of glutathione.

Read more
24 Sep 2020
publication

Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa.

Read more
10 Aug 2020
news

Gut microbiota plays a role in brain function and mood regulation

Read more
17 Dec 2019
publication

CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy

Read more
01 Sep 2019
publication

A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals.

Read more
30 Aug 2019
event

Department of Immunology seminar: Harry Sokol, Gut Microbiome, intestinal inflammation and Tryptophan Metabolism

Read more
17 Jun 2019
publication

Recombinant Antibodies against Mycolactone

Read more
21 May 2019
event

Department of Immunology seminar: Alan Korman, Tumor Immunotherapy and a pH Selective Pathway for Immune Regulation

Read more
06 May 2019
publication

Ipomoeassin F Binds Sec61α to Inhibit Protein Translocation

Read more
28 Jul 2018
publication

Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease

Read more
27 Jul 2018
publication

Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.

Read more
18 Jun 2018
publication

Proteomics reveals scope of mycolactone-mediated Sec61 blockade and distinctive stress signature

Read more
17 Nov 2017
publication

Mycolactone displays anti-inflammatory effects on the nervous system

Read more
07 Oct 2017
news

Microbes, Immunity and Metabolism international conference, November 15th-17th, 2017

Read more
20 Sep 2017
publication

Modular total syntheses of mycolactone A/B and its [(2)H]-isotopologue

Read more
05 Jul 2017
publication

Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export

Read more
14 Jun 2017
publication

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.

Read more
06 Apr 2017
event

MIM 2017 “Microbes, Immunity and Metabolism international conference”

Read more
18 Mar 2017
publication

Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids

Read more
12 Dec 2016
publication

Mycolactone subverts immunity by selectively blocking the Sec61 translocon.

Read more
25 Oct 2016
event

Department of Immunology seminar: Oliver Neyrolles

Read more
30 Sep 2016
event

Jonathan Kagan seminar

Read more
06 Sep 2016
publication

Standardized Whole-Blood Transcriptional Profiling Enables the Deconvolution of Complex Induced Immune Responses.

Read more
07 Jun 2016
event

Seminaire conjoint du departement d’immunologie et departement de biologie du développement & cellules souches

Read more
27 May 2016
event

Immunology department seminar

Read more
04 Dec 2015
publication

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

Read more
07 Aug 2015
project

BURULI Path: the subversive role of mycolactone

Read more
27 May 2015
publication

Shaping mycolactone for therapeutic use against inflammatory disorders.

Read more
11 May 2015
team

Integrated Mycobacterial Pathogenomics

Read more
11 May 2015
team

Immunobiology and Therapy

Read more
15 Sep 2014
department

Immunology

Read more
02 Sep 2014
publication

Synthetic variants of mycolactone bind and activate Wiskott-Aldrich syndrome proteins

Read more
01 Aug 2014
publication

Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings

Read more
10 Apr 2014
publication

Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.

Read more
21 Jan 2014
publication

Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens

Read more
02 Jul 2013
publication

Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected]

Read more
15 Mar 2013
publication

Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation

Read more
01 Jun 2012
publication

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer

Read more
08 May 2012
publication

ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria

Read more
30 Nov 2011
publication

A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins

Read more
19 Jul 2011
publication

Mycolactone diffuses into the peripheral blood of Buruli ulcer patients–implications for diagnosis and disease monitoring

Read more
18 Jul 2011
publication

Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression.

Read more
21 Oct 2010
publication

Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes

Read more
01 Dec 2009
publication

Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease

Read more
26 May 2009
publication

Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression

Read more
07 Feb 2009
publication

Buruli ulcer disease: prospects for a vaccine

Read more
01 Jan 2009
publication

Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans

Read more
22 Oct 2008
publication

Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs

Read more
17 Apr 2008
publication

Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria

Read more
23 Nov 2007
publication

A novel mycolactone toxin obtained by biosynthetic engineering

Read more
21 May 2007
publication

Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone

Read more
01 Sep 2006
publication

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence

Read more
26 May 2006
publication

Towards an immunodiagnostic test for leprosy

Read more
24 May 2006
publication

Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer

Read more
01 Jan 2006
publication

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence

Read more
01 Jan 2006
publication

Antigen discovery: a postgenomic approach to leprosy diagnosis

Read more
01 Aug 2005
publication

Tuberculosis: from genome to vaccine

Read more
01 Aug 2005
publication

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

Read more
01 Apr 2005
publication

Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens

Read more
10 Dec 2004
publication

Single chain antibody fragments for the selective targeting of antigens to dendritic cells

Read more
15 Jun 2004
publication

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.

Read more
01 Apr 2004
publication

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6

Read more
14 Apr 2003
publication

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

Read more
01 May 2002
publication

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

Read more
01 Apr 2002
publication

Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production

Read more
01 Aug 2001
publication

Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism

Read more
01 Jun 2001
publication

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

Read more
01 Apr 2001
publication

Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope

Read more
01 Apr 2001
publication

Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection

Read more
01 Aug 2000
publication

Interaction of dendritic cells with mycobacteria: where the action starts

Read more
01 Apr 2000
publication

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

Read more
01 Apr 2000
publication

Combining phage display and molecular modeling to map the epitope of a neutralizing antitoxin antibody

Read more
01 Jun 1999
publication

Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells

Read more
01 May 1999
publication

Molecular mimicry between a monoclonal antibody and one subunit of crotoxin, a heterodimeric phospholipase A2 neurotoxin

Read more
01 Jan 1998
publication

Phage-displayed mimotopes elicit monoclonal antibodies specific for a malaria vaccine candidate

Read more
01 Sep 1997
publication

Phage-displayed and soluble mouse scFv fragments neutralize rabies virus

Read more
01 Jun 1997
publication

Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library

Read more
01 Aug 1996
publication

Reproducing the immune response against the Plasmodium vivax merozoite surface protein 1 with mimotopes selected from a phage-displayed peptide library

Read more
01 Jan 1993
publication

An attempt to correlate cattle breed origins and diseases associated with or transmitted by the tick Amblyomma variegatum in the French West Indies

Read more
01 Sep 1992
publication

Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]

Read more
01 Jun 1992
publication

Role of metabolic waste products in the control of cell proliferation and antibody production by mouse hybridoma cells

Read more
01 Sep 1991
publication

Factors controlling cell proliferation and antibody production in mouse hybridoma cells: I. Influence of the amino acid supply

Read more
01 Dec 1990
publication

Comparison of various methods for monitoring hybridoma cell proliferation

Read more